Influence of age on the efficacy of pharmacologic treatments on fracture risk reduction and increases in BMD: RCT results from the FNIH-ASBMR-SABRE project
Journal of Bone and Mineral Research · 2024
DOI: 10.1093/jbmr/zjae040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bone and Mineral Research, 2024. Verfasst von Marian Schini und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, S10 2TN, United Kingdom. Hauptthemen laut MEDLINE: Bone Density. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: FDA HHS, American Society for Bone Mineral Research, FDA.
Abstract (Originalsprache)
There is a common belief that antiosteoporosis medications are less effective in older adults. This study used data from randomized controlled trials (RCTs) to determine whether the anti-fracture efficacy of treatments and their effects on BMD differ in people ≥70 compared to those <70 yr. We used individual patient data from 23 RCTs of osteoporosis medications collected as part of the FNIH-ASBMR SABRE project. We assessed the following fractures: radiographic vertebral, non-vertebral, hip, all clinical, and all fractures. We used Cox proportional hazard regression to estimate treatment effect for clinical fracture outcomes, logistic regression for the radiographic vertebral fracture outcome, and linear regression to estimate treatment effect on 24-mo change in hip and spine BMD in each age subgroup. The analysis included 123 164 (99% female) participants; 43% being ≥70 yr. Treatment with anti-osteoporosis drugs significantly and similarly reduced fractures in both subgroups (eg, odds ratio [OR] = 0.47 and 0.51 for vertebral fractures in those below and above 70 yr, interaction P = .19; hazard ratio [HR] for all fractures: 0.72 vs 0.70, interaction P = .20). Results were similar when limited to bisphosphonate trials with the exception of hip fracture risk reduction which was somewhat greater in those <70 (HR = 0.44) vs ≥70 (HR = 0.79) yr (interaction P = .02). Allocation to anti-osteoporotic drugs resulted in significantly greater increases in hip and spine BMD at 24 mo in those ≥70 compared to those <70 yr. In summary, anti-osteoporotic medications similarly reduced the risk of fractures regardless of age, and the few small differences in fracture risk reduction by age were of uncertain clinical significance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, S10 2TN, United Kingdom.
- Department of Epidemiology & Biostatistics, University of California, San Francisco, CA 94158, United States.
- California Pacific Medical Center Research Institute, San Francisco, CA 94158, United States.
- Department of Medicine, University of California, San Francisco, CA 94158, United States.
- Department of Orthopedic Surgery, Harvard Medical School, Center for Advanced Orthopedic Studies, Beth Israel Deaconess Medical Center, Boston, MA 02215330, United States.
ORCID-Profile: Tatiane Vilaca, Richard Eastell
Förderung
- FDA HHS
- American Society for Bone Mineral Research
- FDA
Zitieren
APA
Schini, M., Vilaca, T., Vittinghoff, E., Lui, L. Y., Ewing, S. K., Thompson, A. R., Bauer, D. C., Bouxsein, M. L., Black, D. M., & Eastell, R. (2024). Influence of age on the efficacy of pharmacologic treatments on fracture risk reduction and increases in BMD: RCT results from the FNIH-ASBMR-SABRE project. Journal of Bone and Mineral Research. https://doi.org/10.1093/jbmr/zjae040
Vancouver
Schini M, Vilaca T, Vittinghoff E, Lui LY, Ewing SK, Thompson AR, et al. Influence of age on the efficacy of pharmacologic treatments on fracture risk reduction and increases in BMD: RCT results from the FNIH-ASBMR-SABRE project. Journal of Bone and Mineral Research. 2024. doi:10.1093/jbmr/zjae040
BibTeX
@article{Schini2024,
author = {Schini, Marian and Vilaca, Tatiane and Vittinghoff, Eric and Lui, Li-Yung and Ewing, Susan K and Thompson, Austin R and Bauer, Douglas C and Bouxsein, Mary L and Black, Dennis M and Eastell, Richard},
title = {Influence of age on the efficacy of pharmacologic treatments on fracture risk reduction and increases in BMD: RCT results from the FNIH-ASBMR-SABRE project},
journal = {Journal of Bone and Mineral Research},
year = {2024},
doi = {10.1093/jbmr/zjae040}
}
EUVIMED